bioMérieux S.A. (EPA:BIM)

France flag France · Delayed Price · Currency is EUR
69.80
-1.50 (-2.10%)
Apr 28, 2026, 5:35 PM CET
-39.57%
Market Cap 8.41B
Revenue (ttm) 4.07B
Net Income (ttm) 397.50M
Shares Out 117.95M
EPS (ttm) 3.34
PE Ratio 21.35
Forward PE 15.75
Dividend 0.98 (1.37%)
Ex-Dividend Date Jun 9, 2026
Volume 282,474
Average Volume 183,813
Open 71.30
Previous Close 71.30
Day's Range 69.80 - 71.55
52-Week Range 69.80 - 128.30
Beta 0.67
RSI 16.88
Earnings Date Jul 28, 2026

About bioMérieux

bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments. The company offers CHROMID RANGE, a chromogen culture media; air, surface, and water monitoring systems; BACT/ALERT VIRTUO, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system (PCR); BIOFIRE SPOTFIRE, a lowplex PCR point-of... [Read more]

Sector Healthcare
Founded 1963
Employees 15,226
Stock Exchange Euronext Paris
Ticker Symbol BIM
Full Company Profile

Financial Performance

In 2025, bioMérieux's revenue was 4.07 billion, an increase of 2.26% compared to the previous year's 3.98 billion. Earnings were 397.50 million, a decrease of -8.03%.

Financial Statements

News

There is no news available yet.